跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
恩替卡韦片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Entecavir Tablets
Approved
化学药品
Entecavir Tablets
SANDOZ PHARMACEUTICALS D.D.
🇨🇳 National Medical Products Administration
Approval Date
Mar 23, 2021
Approval ID
887Y5Oh8bKt
Company
SANDOZ PHARMACEUTICALS D.D.
Type
化学药品
Approval Details
Approval Id
887Y5Oh8bKt
Approval Number
国药准字HJ20210015
Generic Name
恩替卡韦片
Generic Name En
Entecavir Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5mg
Reg Date
2021-03-23
Expired Date
2026-03-22
Company Name
SANDOZ PHARMACEUTICALS D.D.
Company Address
Verovskova ulica 57, 1000 Ljubljana, Slovenia
Production Company Name
Lek Pharmaceuticals dd
Production Company Address
Verovskova ulica 57, 1526 Ljubljana, Slovenia
Company Detail Path
/organization/sandoz-pharmaceuticals-d-d
Production Company Detail Path
/organization/lek-pharmaceuticals-dd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 23, 2021
Approval ID
887Y5Oh8bKt
Type
化学药品
Back to NMPA Approvals